Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

3 years ago

-- Announced preclinical data providing further proof-of-concept for Prime Editing’s ability to achieve restoration of genetic function, as well as…

Femasys Inc. to Participate in “The Post-Roe Fertility Journey” Panel Discussion at SXSW 2023

3 years ago

ATLANTA, March 09, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide…

Arcutis to Present New Topical Roflumilast Data Including Late Breaking Atopic Dermatitis Pivotal Trial Data During the American Academy of Dermatology (AAD) Annual Meeting

3 years ago

Late breaking session to highlight new data from the INTEGUMENT Phase 3 trials evaluating roflumilast cream in atopic dermatitisNew national…

Novel Target-Specific Nanoparticles for Diagnosis and Treatment of Pancreatic Cancer

3 years ago

By Dr. Jill Smith Pancreatic cancer is well known as one of the deadliest cancers, with a paltry 11% survival…

Molecure announces first patient dosed in Phase I trial with novel, first-in-class dual arginase inhibitor OATD-02 for the treatment of cancer

3 years ago

Marcin Szumowski Chief Executive Officer Samson Fung Chief Medical Officer OATD-02 First-in-class dual arginase inhibitorMolecure announces first patient dosed in…

Smile Health Orthodontics (SHO) Now Offering Patients 3D Printed Clear Aligners & 3D Printed LightForce Ceramic Braces

3 years ago

Patients can safely and comfortably accelerate their treatment compared to traditional metal braces A 3D printed model fresh out of…

Adial Pharmaceuticals to Present at the 35th Annual Roth Conference on March 14th

3 years ago

CHARLOTTESVILLE, Va., March 08, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage…

Novan Moves Forward with Unified Corporate Branding

3 years ago

– Novan is a fully integrated pharmaceutical company with proven capabilities across drug development through to commercialization – – EPI…

Capricor Therapeutics to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on March 15

3 years ago

-Company to Host Conference Call, March 15, 2023, at 4:30 p.m. ET-SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Capricor…

Editas Medicine Strengthens Executive Leadership Team with Appointment of Linea Aspesi as Chief People Officer

3 years ago

Linea Aspesi Linea Aspesi, Executive Vice President and Chief People Officer, Editas MedicineCAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) --…